Maybury, B. DJames, LChadderton, NDowds, JVenkatadasari, IRiley, JQureshi, ITalbot, GGiles, H. VPhillips, N. JGonzalez, M. VegaRakesh, PHaslam, ADavies, DMoosai, SLane, S AShenouda, ACherian, G. VKaudlay, P. KStarczynski, J et al2025-01-222025-01-222023-06-01B. D. Maybury, L. James, N. Chadderton, J. Dowds, I. Venkatadasari, J. Riley, I. Qureshi, G. Talbot, H. V. Giles, N. J. Phillips, M. Vega Gonzalez, P. Rakesh, A. Haslam, D. Davies, S. Moosai, S. A. Lane, A. Shenouda, G. V. Cherian, P. K. Kaudlay, J. Starczynski, Z. Rudzki, S. Chaganti. MYC/BCL6 double hit lymphoma negative for t(3;8) bcl610.1002/hon.3163_134http://hdl.handle.net/20.500.14200/7090A small proportion of large B cell non-Hodgkin lymphoma (NHL) has�MYC�and�BCL6�rearrangements, detectable by fluorescence in-situ hybridisation (FISH) break-apart probes. There are conflicting reports on the prognosis of this group. A proportion of them have a single�t(3;8)�BCL6Hematological Oncology